MYH9 and hepatocellular carcinoma: Moreover, survival analysis illustrated that MYH9 expression levels were positively associated with poor patient prognosis (median survival of 19 months for the high MYH9 group versus 49 months for the low MYH9 group) (log-rank test, P = 0.0292) (Fig. 6c).33 Importantly, univariate and multivariate analyses suggested that MYH9 expression was an independent indicator for the overall survival of HCC patients (Fig. 6d).